Osteochondroma

Osteochondroma is an extensive benign bone tumor that arises from cartilage tissue and is often located on the surface of bones, mainly in the metaphyseal region of long bones such as the femur and tibia. It is one of the most common diseases among benign bone formations and in most cases occurs in adolescents and young adults, which is associated with active tissue growth. Osteochondroma can be single or multiple, with multiple forms being associated with hereditary syndromes such as hereditary multiple osteochondromatosis. The tumor often manifests itself without symptoms, but in some cases it can cause pain, especially with mechanical impact or injury, and can also cause neurological disorders when surrounding structures are compressed.

History of the disease and interesting historical facts

The history of osteochondroma goes back more than a hundred years. In 1875, the Swedish surgeon and pathologist D. P. Lund made the first description of this disease. Since then, osteochondroma has attracted the attention of many researchers. For example, at the end of the 19th century, several cases were recorded in which osteochondroma was detected in patients with multiple exostoses syndrome. In the 1950s, scientists began to divide osteochondroma into single and multiple forms, which made it possible to study their etiology and pathogenesis in more depth.

Epidemiology

According to the literature, osteochondroma occurs with a frequency of 1 to 2 cases per 1000 people. It is known that the pathology is diagnosed more often in men than in women, the ratio is approximately 2:1. In most cases, osteochondroma occurs in people aged 10 to 25 years. About 10% cases of osteochondroma are asymptomatic and are discovered accidentally during an X-ray examination for another pathology. Some patients have multiple osteochondromas, which requires additional clinical and genetic monitoring.

Genetic predisposition to this disease

There is evidence of a genetic predisposition to osteochondroma. Among the genes involved are EXT1 and EXT2, mutations in which are associated with the development of multiple osteochondroma. These genes encode proteins involved in the synthesis of heparan sulfate and, therefore, play an important role in the normal metabolism of cartilage tissue. Some studies indicate the possibility of mutations in genes responsible for chondrogenesis and bone formation, which may also be associated with the development of osteochondroma.

Risk factors for the development of this disease

Despite the largely genetic nature of osteochondroma, certain factors can increase the risk of its development. These include:

• Physical factors: repeated trauma or overexertion of the bone growth area.
• Chemical factors: exposure to certain chemicals, such as carcinogens, which can affect tissue structure.
• Associated diseases: The presence of other bone diseases or metabolic disorders can contribute to the development of osteochondroma.

Diagnosis of this disease

Diagnosis of osteochondroma is based on clinical, laboratory and radiological data. The main symptoms are:

• Pain in the area of the formation, especially during physical activity.
• A tumor that can be felt on physical examination.
• Limited mobility in the joint located next to the osteochondroma.

Laboratory tests, although not specific, may include a complete blood count and biochemistry profile to check for inflammatory processes. Radiological examinations such as X-rays, CT scans, and MRIs are key to identifying osteochondroma. They help determine the size, location, and nature of the tumor and rule out malignant transformation. Differential diagnosis includes tumor distribution such as osteosarcoma and chondrosarcoma.

Treatment

Osteochondroma usually requires treatment if symptoms such as pain or compression of nearby tissues occur. Common treatments include:

• General treatment: lifestyle changes and minimization of physical stress on the affected limb.
• Pharmacological treatment: use of nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve symptoms.
• Surgical treatment: indicated when symptoms such as pain or nerve compression are present. Typically involves resection of the osteochondroma.
• Other treatments: Physical therapy to improve limb function.

List of medications used to treat this disease

The main medications used to treat osteochondroma include:

• Ibuprofen
• Naproxen
• diclofenac
• Celecoxib
• Ketoprofen

Disease monitoring

Monitoring of osteochondroma involves regular follow-up examinations to track changes in the size and structure of the tumor. The prognosis is favorable in most cases, since osteochondroma is benign. However, malignant transformation is sometimes observed, which requires more careful monitoring. Possible complications may include compression of surrounding structures, bone deformation, and neurological symptoms.

Age-related features of the disease

Osteochondroma is usually observed in young people and children during the period of active growth. In childhood, it can be asymptomatic and appear accidentally. In adults, the disease is less common, and in the elderly, osteochondroma is extremely rare.

Questions and Answers

• What is osteochondroma? Osteochondroma is a benign bone tumor that arises in cartilage, often in the metaphyses of long bones.
• What are the causes of osteochondroma? Osteochondroma can develop as a result of genetic mutations, injury, or protein and cartilage growth factors.
• How is osteochondroma treated? Treatment may include tumor observation, anti-inflammatory drugs, and surgical resection if symptomatic.
• What is the probability of malignant transformation of osteochondroma? The probability of malignant transformation is not high, it is less than 1%, but requires careful monitoring.
• At what age does osteochondroma most often occur? The disease is most often diagnosed in adolescents and young adults aged 10 to 25 years.